SymbioCellTech
Blood & Organ Banks · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
615 S Arapeen Dr Ste 210, Salt Lake City...Phone Number
(801) 503-3990Website
www.symbiocelltech.comRevenue
<$5 MillionIndustry
About SymbioCellTech
SymbioCellTech is dedicated to developing next-generation therapies for Type 1 Diabetes, aiming to eliminate the need for daily insulin injections and reduce complications associated with the disease. Their innovative Neo-Islet technology seeks to cure Type 1 Diabetes without the use of immuno-suppressive agents that can negatively impact patients' quality of life. The company targets individuals suffering from Type 1 Diabetes, particularly the 16 million people affected in the United States. Recently, they were recognized as the 2024 winner of the American Diabetes Association's Innovation Challenge Award.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSymbioCellTech Org Chart
SymbioCellTech Tech Stack
A closer look at the technologies used by SymbioCellTech
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SymbioCellTech
Sign Up For FreeTo access detailed company insights
SymbioCellTech is dedicated to developing next-generation therapies for Type 1 Diabetes, aiming to eliminate the need for daily insulin injections and reduce complications associated with the disease. Their innovative Neo-Islet technology seeks to cure Type 1 Diabetes without the use of immuno-suppressive agents that can negatively impact patients'... Read More